The “Diabetes Drug Delivery Devices Market, 2020-2030” report features an extensive study of the current market landscape and the likely adoption of diabetes drug delivery devices, over th

To order this 240+ page report, please visit this link

Key Inclusions

• An overview of the current market landscape of diabetes drug delivery devices available for delivery of insulin and non-insulin drugs, including information on device specifications, such as type of device (insulin pump, pen-injector / autoinjector, jet injector, microneedle patch, nasal delivery system, insulin port, oral delivery system and inhalation device), stage of development (marketed, clinical and preclinical), route of administration (subcutaneous, intramuscular, transdermal, oral, intranasal and others), mode of drug delivery (invasive, minimally invasive and non-invasive), needle attributes (needleless, detachable needle, cannula, hidden needle and fixed needle), type of drug delivery system (mechanical method and electrical method), drug administration speed (fast and slow), device usability (disposable, reusable and reusable (disposable components)), diabetes type (type I diabetes, type II diabetes and diabetes type (unspecified)) and type of drug (insulin and non-insulin). In addition, the report present the details of the companies developing these devices, including information on type of developer (industry and non-industry), year of establishment, company size and location of headquarters. 
• A detailed competitiveness analysis of diabetes drug delivery devices based on various relevant parameters, such as supplier power (based on the experience / expertise of the developer) and product specifications (type of device, route of administration, diabetes type, needle attributes, availability of needle safety system, self-administration potential, mode of drug delivery, device usability, drug administration speed and development stage).
• An analysis of the partnerships that have been inked by the stakeholders in this domain, during the period between 2015 and 2020, covering technology integration agreements, product development agreements, distribution agreements, acquisitions, product commercialization agreements, supply agreements, licensing agreements, product development and commercialization agreements and other relevant types of deals.
• Elaborate profiles of the prominent players developing diabetes drug delivery devices. Each company profile features a brief overview of the company, its financial information (if available), information on its product portfolio, recent developments and an informed future outlook.
• A review of recent initiatives undertaken by big pharma players engaged in this domain. It also features a benchmark analysis of top 10 big pharma players (in terms of annual revenues of 2019), based on their initiatives related to diabetes drug delivery devices.

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

• Type of Device
• Pen-Injectors
• Insulin Pumps
• Conventional Syringes
• Others

• Route of Administration
• Subcutaneous
• Intravenous
• Others

• Type of Diabetes
• Type 1
• Type 2
• Usability of the Device
• Disposable
• Reusable

• Key Geographies
• North America
• Europe
• Asia Pacific
• Rest of the World

To request sample pages, please visit this link

Key Questions Answered

• Who are the leading players engaged in the development of diabetes drug delivery devices?
• What are the popular devices types that are available / under development for the delivery of diabetes medicine?
• What kind of novel / advanced features are device developers incorporating into their proprietary offerings in order to maintain a competitive edge in the market?
• What kind of partnership models are commonly being adopted by stakeholders in this industry?
• What is the role of big pharma companies in this market?
• What are the factors that are likely to influence the evolution of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

You may also be interested in the following titles:

1. Organ–based / Targeted Drug Delivery Devices Market for Biologics (Intra-organ / Intra-tumoral), 2020 - 2030
2. Global Handheld Ultrasound Imaging Devices Market, 2020-2030
3. Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices
4. Medical Device CROs Market (2nd Edition), 2020 – 2030

Contact Us

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]